258 related articles for article (PubMed ID: 10069780)
1. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
Miyazaki H; Matsuoka H; Cooke JP; Usui M; Ueda S; Okuda S; Imaizumi T
Circulation; 1999 Mar; 99(9):1141-6. PubMed ID: 10069780
[TBL] [Abstract][Full Text] [Related]
2. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort.
Maas R; Xanthakis V; Polak JF; Schwedhelm E; Sullivan LM; Benndorf R; Schulze F; Vasan RS; Wolf PA; Böger RH; Seshadri S
Stroke; 2009 Aug; 40(8):2715-9. PubMed ID: 19498184
[TBL] [Abstract][Full Text] [Related]
3. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
Notsu Y; Yano S; Shibata H; Nagai A; Nabika T
Atherosclerosis; 2015 Mar; 239(1):61-6. PubMed ID: 25576847
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study.
Furuki K; Adachi H; Matsuoka H; Enomoto M; Satoh A; Hino A; Hirai Y; Imaizumi T
Atherosclerosis; 2007 Mar; 191(1):206-10. PubMed ID: 16672157
[TBL] [Abstract][Full Text] [Related]
6. Relationship between asymmetric dimethylarginine and asymptomatic carotid atherosclerosis.
Riccioni G; Bucciarelli V; Scotti L; Aceto A; D Orazio N; Di Ilio E; Bucciarelli T
J Biol Regul Homeost Agents; 2010; 24(3):351-8. PubMed ID: 20846483
[TBL] [Abstract][Full Text] [Related]
7. Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-media thickness progression: six-year prospective study using carotid ultrasonography.
Furuki K; Adachi H; Enomoto M; Otsuka M; Fukami A; Kumagae S; Matsuoka H; Nanjo Y; Kakuma T; Imaizumi T
Hypertens Res; 2008 Jun; 31(6):1185-9. PubMed ID: 18716367
[TBL] [Abstract][Full Text] [Related]
8. Is asymmetric dimethylarginine a novel marker of atherosclerosis?
Böger RH; Bode-Böger SM; Matsuoka H; Miyazaki H; Usui M; Ueda S; Okuda S; Imaizumi T; Cooke JP
Circulation; 2000 Apr; 101(14):E160-1. PubMed ID: 10758065
[No Abstract] [Full Text] [Related]
9. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
Lu TM; Ding YA; Charng MJ; Lin SJ
Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients.
Turiel M; Atzeni F; Tomasoni L; de Portu S; Delfino L; Bodini BD; Longhi M; Sitia S; Bianchi M; Ferrario P; Doria A; De Gennaro Colonna V; Sarzi-Puttini P
Rheumatology (Oxford); 2009 Jul; 48(7):834-9. PubMed ID: 19465588
[TBL] [Abstract][Full Text] [Related]
11. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
[TBL] [Abstract][Full Text] [Related]
12. ADMA/SDMA in elderly subjects with asymptomatic carotid atherosclerosis: values and site-specific association.
Riccioni G; Scotti L; D'Orazio N; Gallina S; Speziale G; Speranza L; Bucciarelli T
Int J Mol Sci; 2014 Apr; 15(4):6391-8. PubMed ID: 24739810
[TBL] [Abstract][Full Text] [Related]
13. Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension.
Serg M; Kampus P; Kals J; Zagura M; Muda P; Tuomainen TP; Zilmer K; Salum E; Zilmer M; Eha J
Blood Press; 2011 Apr; 20(2):111-6. PubMed ID: 21142418
[TBL] [Abstract][Full Text] [Related]
14. Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis.
Zsuga J; Torok J; Magyar MT; Valikovics A; Gesztelyi R; Kéki S; Csiba L; Zsuga M; Bereczki D
Cerebrovasc Dis; 2007; 23(5-6):388-94. PubMed ID: 17406107
[TBL] [Abstract][Full Text] [Related]
15. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects.
Holven KB; Haugstad TS; Holm T; Aukrust P; Ose L; Nenseter MS
Br J Nutr; 2003 Mar; 89(3):359-63. PubMed ID: 12628031
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials.
Böger RH
Vasc Med; 2005 Jul; 10 Suppl 1():S19-25. PubMed ID: 16444865
[TBL] [Abstract][Full Text] [Related]
17. Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis.
Atzeni F; Sarzi-Puttini P; Sitia S; Tomasoni L; Gianturco L; Battellino M; Boccassini L; De Gennaro Colonna V; Marchesoni A; Turiel M
J Rheumatol; 2011 Aug; 38(8):1661-4. PubMed ID: 21632673
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Notsu Y; Nabika T; Bokura H; Suyama Y; Kobayashi S; Yamaguchi S; Masuda J
Am J Hypertens; 2009 Mar; 22(3):257-62. PubMed ID: 19057516
[TBL] [Abstract][Full Text] [Related]
19. Carotid intima-media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginine.
Sen N; Poyraz F; Tavil Y; Yazici HU; Turfan M; Hizal F; Topal S; Erdamar H; Cakir E; Yalçin R; Cengel A
Atherosclerosis; 2009 Jun; 204(2):e82-5. PubMed ID: 19010468
[TBL] [Abstract][Full Text] [Related]
20. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
Selley ML
Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
